Posted by Michael Wonder on 29 Jan 2016
Avanir Pharmaceuticals announces FDA approval of Onzetra Xsail (AVP-825) for the acute treatment of migraine in adults
28 January 2016 - Onzetra Xsail is a fast-acting dry powder formulation of sumatriptan, the most commonly prescribed migraine medication.
For more details, go to: http://www.avanir.com/press/avanir-pharmaceuticals-announces-fda-approval-onzetra™-xsail™-avp-825-acute-treatment-migraine
